Literature DB >> 5702295

Calcium metabolism in acromegaly.

A Nadarajah, M Hartog, B Redfern, N Thalassinos, A D Wright, G F Joplin, T R Fraser.   

Abstract

A total of 78 acromegalic patients were studied before and after treatment by yttrium-90 needle implantation.Among the untreated patients 16% had a borderline or raised serum calcium. In half of these patients the serum calcium fell to normal after remission of their acromegaly. In the others the hypercalcaemia was due to associated proved or probable hyperparathyroidism. A downward trend of the serum calcium was noted even in the normocalcaemic patients with remission of their disease.Only 20% of untreated patients had a raised serum phosphate, and follow-up showed this measurement to be a poor index of disease activity.Net calcium absorption and calcium balances in five patients in this series and 12 others from the literature were essentially normal for their given level of calcium intake. No patient showed definite radiological evidence of osteoporosis and vertebral fractures.Bone uptake rate of calcium-47 and stable strontium was raised in the untreated state in all nine patients studied. The 24-hour strontium space was raised in 73% of untreated patients and fell to normal after treatment in all the retested patients in whom it was high initially.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5702295      PMCID: PMC1912990          DOI: 10.1136/bmj.4.5634.797

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  18 in total

1.  ENDOCRINE ADENOMATOSIS AND PEPTIC ULCER IN A LARGE KINDRED. INHERITED MULTIPLE TUMORS AND MOSAIC PLEIOTROPISM IN MAN.

Authors:  P WERMER
Journal:  Am J Med       Date:  1963-08       Impact factor: 4.965

Review 2.  HUMAN PITUITARY GROWTH HORMONE.

Authors:  W H DAUGHADAY; M L PARKER
Journal:  Annu Rev Med       Date:  1965       Impact factor: 13.739

3.  Ulnar bone mineral concentration in metabolic bone diseases.

Authors:  F H DOYLE
Journal:  Br J Radiol       Date:  1961-11       Impact factor: 3.039

4.  Skeletal dynamics in man measured by nonradioactive strontium.

Authors:  E EISENBERG; G S GORDAN
Journal:  J Clin Invest       Date:  1961-10       Impact factor: 14.808

5.  The roentgenologic features of acromegaly.

Authors:  E K LANG; W T BESSLER
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1961-08

6.  Metabolic and renotropic effects of human growth hormone in disease.

Authors:  H GERSHBERG
Journal:  J Clin Endocrinol Metab       Date:  1960-08       Impact factor: 5.958

7.  STUDIES OF CALCIUM AND PHOSPHORUS METABOLISM. XVI. THE INFLUENCE OF THE PITUITARY GLAND.

Authors:  W Bauer; J C Aub
Journal:  J Clin Invest       Date:  1941-05       Impact factor: 14.808

8.  Studies of 47Ca metabolism in acromegaly.

Authors:  N H Bell; F C Bartter
Journal:  J Clin Endocrinol Metab       Date:  1967-02       Impact factor: 5.958

9.  Hyperparathyroidism in acromegaly. Findings in three cases.

Authors:  V K Summers; W R Hunter; L J Hipkin; J C Davis
Journal:  Lancet       Date:  1966-09-17       Impact factor: 79.321

10.  Acromegaly and hyperparathyroidism.

Authors:  M Hartog
Journal:  Proc R Soc Med       Date:  1967-05
View more
  8 in total

1.  Osteopenia occurs in a minority of patients with acromegaly and is predominant in the spine.

Authors:  M J Kayath; J G Vieira
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

Review 2.  The pathophysiology and clinical aspects of hypercalcemic disorders.

Authors:  D B Lee; E T Zawada; C R Kleeman
Journal:  West J Med       Date:  1978-10

3.  Endocrine bone disease.

Authors:  G F Joplin
Journal:  Proc R Soc Med       Date:  1973-05

Review 4.  Human pituitary disease.

Authors:  R Fraser
Journal:  Br Med J       Date:  1970-11-21

5.  Characterization of vitamin D metabolism in active acromegaly in the setting of bolus (150,000 IU) cholecalciferol treatment.

Authors:  Alexandra A Povaliaeva; Viktor P Bogdanov; Artem Yu Zhukov; Ekaterina A Pigarova; Larisa K Dzeranova; Liudmila Ya Rozhinskaya; Galina A Mel'nichenko; Natalia G Mokrysheva
Journal:  Endocrine       Date:  2022-02-09       Impact factor: 3.633

6.  Fracture risk is decreased in acromegaly--a potential beneficial effect of growth hormone.

Authors:  Peter Vestergaard; Leif Mosekilde
Journal:  Osteoporos Int       Date:  2003-11-19       Impact factor: 4.507

7.  Role of growth hormone in experimental phosphorus deprivation in the rat.

Authors:  D B Lee; N Brautbar; M W Walling; V Silis; H E Carlson; R E Grindeland; J W Coburn; C R Kleeman
Journal:  Calcif Tissue Int       Date:  1980       Impact factor: 4.333

Review 8.  Acromegaly and non-parathyroid hormone-dependent hypercalcemia: a case report and literature review.

Authors:  Shaomin Shi; Lan Zhang; Yerong Yu; Chun Wang; Jianwei Li
Journal:  BMC Endocr Disord       Date:  2021-05-01       Impact factor: 3.263

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.